MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s...
Coronavirus
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider...
Pulse Oximetry Market size is set to grow by USD 1.18 billion from 2024-2028, Increasing prevalence of chronic respiratory diseases to boost the market growth, Technavio
NEW YORK, July 19, 2024 /PRNewswire/ -- The global pulse oximetry market size is estimated to grow by USD 1.18 billion from 2024-2028,...
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable...
A Single Drug Against Multiple Respiratory Virus Infections – COVID, RSV, Influenza, Bird Flu – Planning Next Phase of Clinical Trials, Says NanoViricides
SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
Services PMI® at 48.8%; June 2024 Services ISM® Report On Business®
Business Activity Index at 49.6%; New Orders Index at 47.3%; Employment Index at 46.1%; Supplier Deliveries Index at 52.2% TEMPE,...
Sapiens Accelerates Growth for Medical Professional Liability Insurers
Sapiens' expanded offering maximizes business value for MPL insurers, supporting growth and retention ROCHELLE PARK, N.J., July 2, 2024...
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
SEATTLE, WA / ACCESSWIRE / July 1, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant
Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian...
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage global leader...
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.:NNVC) (the "Company"), a clinical stage company and...
New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in...
Resonate Data Shows Consumer Economic and Health Concerns are Stabilizing
After years of rising anxiety, Americans are ready for a pause RESTON, Va., June 18, 2024 /PRNewswire/ -- Resonate, a pioneer...
Emergex Announces MHRA Approval of MIA (IMP) Manufacturing and Import Authorisation License
ABINGDON, United Kingdom, June 18, 2024 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited (‘Emergex’, or the ‘Company’), a clinical-stage biotechnology company...
Replimune Announces $100 Million Private Placement Financing
- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON, CT...
Hospital PMI® at 58.4%; May 2024 Hospital ISM® Report On Business®
TEMPE, Ariz., June 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in May for the ninth consecutive month after...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending...
ISM® Welcomes Steve Miller as Esteemed Chair of ISM Services Business Survey Committee
Anthony S. Nieves announces transition after distinguished leadership in chair role for over a decade TEMPE, Ariz., June 6, 2024...
Services PMI® at 53.8%; May 2024 Services ISM® Report On Business®
Business Activity Index at 61.2%; New Orders Index at 54.1%; Employment Index at 47.1%; Supplier Deliveries Index at 52.7% TEMPE,...